Drugs & Clinical Trials | By May 26, 2008 | By Robert Yourell, MAcloseRobert Yourell, MA Name: Robert Yourell
Site: http://www.Yourell.com
See All Articles by Author (41)
About: Mr. Yourell is a member of the American Counseling Association with extensive experience in the mental health and social services fields dating back to 1975. His training includes Ericksonian communication and hypnosis with John Grinder, EMDR, level 2 (Eye Movement Desensitization and Reprocessing) with Francine Shapiro, Ph.D., Body Integrative Psychotherapy with Jack Rosenberg, Ph.D., TFT, level 2 (Thought Field Therapy) with Gary Craig, EFT level 2, (Emotional Freedom Technique), and solution-focused psychotherapy. | 2 Comments

The Score at Medscape: Meds 9 and the Rest of the Universe 1

I’m never surprised at the power big pharma has over the media, especially media directed at physicians. For once, I’d like to talk back. Here’s a perfect opportunity! I’m going to talk back at an article recently posted to MedScape.com — a source of very informative, thoughtful, brainwashing, and useful information for physicians. This article is about individualizing adult ADD treatment:

To review the latest clinical thinking in this field, Medscape’s Randall F. White, MD, spoke with Richard H. Weisler, MD. Dr. Weisler, a busy clinician and researcher, is adjunct professor of psychiatry at the University of North Carolina at Chapel Hill, and adjunct associate professor of psychiatry at Duke University Medical Center in Durham, North Carolina.

Read more →